Suchitra Jena

1 month ago | biorxiv.org | Nikhil Bhalla |Shweta Chaudhary |Nanaocha Sharma |Suchitra Jena

AbstractBackground: Diabetes and tuberculosis (DMTB) comorbid patients show atypical disease presentation and poor prognosis during treatment. In diabetes, the impaired immune system could partially be explained by the altered gut microbiota. Understanding gut microbiota and their association with the metabolite profiles in DMTB conditions may help design adjunct therapeutics.